Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-02-02 Sale | 2024-02-06 8:18 pm | RIGEL PHARMACEUTICALS INC | RIGL | Santos David A EVP, Chief Commercial Officer | 14,519 | $1.1361 | $16,496 | 349,093 (Direct) | View |
2023-02-02 Sale | 2023-02-06 5:41 pm | RIGEL PHARMACEUTICALS INC | RIGL | Santos David A EVP, Chief Commercial Officer | 5,388 | $1.6602 | $8,945 | 144,612 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-11-25 Option Award | 2024-11-26 8:01 pm | N/A 2033-01-26 | RIGEL PHARMACEUTICALS INC | RIGL | Santos David A EVP, Chief Commercial Officer | 8,000 | $0 | 8,000 (Direct) | View |
2024-02-28 Option Award | 2024-03-01 7:15 pm | N/A 2033-01-26 | RIGEL PHARMACEUTICALS INC | RIGL | Santos David A EVP, Chief Commercial Officer | 158,500 | $0 | 158,500 (Direct) | View |
2024-01-23 Option Award | 2024-01-25 9:17 pm | N/A 2034-01-23 | RIGEL PHARMACEUTICALS INC | RIGL | Santos David A EVP, Chief Commercial Officer | 366,000 | $0 | 520,612 (Direct) | View |
2023-01-26 Option Award | 2023-01-30 9:45 pm | N/A 2032-01-24 | RIGEL PHARMACEUTICALS INC | RIGL | Santos David A EVP, Chief Commercial Officer | 290,000 | $0 | 410,000 (Direct) | View |
2022-12-28 Option Award | 2022-12-30 4:30 pm | N/A 2032-01-24 | RIGEL PHARMACEUTICALS INC | RIGL | Santos David A EVP, Chief Commercial Officer | 50,000 | $0 | 50,000 (Direct) | View |
2022-01-24 Option Award | 2022-01-26 8:45 pm | N/A 2032-01-24 | RIGEL PHARMACEUTICALS INC | RIGL | Santos David A EVP, Chief Commercial Officer | 150,000 | $0 | 160,000 (Direct) | View |
2021-01-27 Option Award | 2021-01-29 7:08 pm | N/A 2031-01-27 | RIGEL PHARMACEUTICALS INC | RIGL | Santos David A EVP, Chief Commercial Officer | 137,500 | $0 | 137,500 (Direct) | View |
2020-08-19 Option Award | 2020-08-20 7:19 pm | N/A 2030-08-19 | RIGEL PHARMACEUTICALS INC | RIGL | Santos David A EVP, Chief Commercial Officer | 250,000 | $0 | 250,000 (Direct) | View |